Table 3.
The table presents demineralized lesions (DLs) on patient level, n (%) and between-group comparisons.
| Fluoride mouth rinse (n = 81) | High-fluoride toothpaste (n = 85) | Control (n = 82) | P-value* | |||
|---|---|---|---|---|---|---|
| MR vs HFT | CTR vs HFT | CTR vs FMR | ||||
| All teeth included | ||||||
| WSL pre-treatment | .76 | .41 | .42 | |||
| 0 | 17 (21.0%) | 22 (25.9%) | 15 (18.3%) | |||
| 1–3 | 33 (40.7%) | 35 (41.2%) | 37 (45.1%) | |||
| 4–8 | 28 (34.6%) | 24 (28.2%) | 21 (25.6%) | |||
| ≥9 | 3 (3.7%) | 4 (4.7%) | 9 (11.0%) | |||
| WSL post-treatment | ||||||
| 0 | 12 (14.8%) | 7 (8.2%) | 6 (7.3%) | .90 | .21 | .21 |
| 1–3 | 19 (23.5%) | 25 (29.4%) | 22 (26.8%) | |||
| 4–8 | 31 (38.3%) | 34 (40.0%) | 28 (34.1%) | |||
| ≥9 | 19 (23.5%) | 19 (22.4%) | 26 (31.7%) | |||
| Patients with an increase of | ||||||
| ≥1 WSL | 53 (65.4%) | 58 (68.2%) | 60 (73.2%) | .71 | .37 | .28 |
| ≥2 WSL | 42 (51.9%) | 48 (56.5%) | 50 (61.0%) | .60 | .42 | .25 |
| ≥3 WSL | 29 (35.8%) | 36 (42.4%) | 41 (50.0%) | .41 | .23 | .076 |
| Teeth in the esthetic zone included | ||||||
| WSL pre-treatment | ||||||
| 0 | 59 (72.8%) | 59 (69.4%) | 58 (70.7%) | .23 | .48 | .42 |
| 1–3 | 21 (25.9%) | 22 (25.9%) | 22 (26.8%) | |||
| ≥4 | 1 (1.2%) | 4 (4.7%) | 2 (2.4%) | |||
| WSL post-treatment | ||||||
| 0 | 23 (28.4%) | 26 (30.6%) | 15 (18.3%) | .71 | .12 | .054 |
| 1–3 | 33 (40.7%) | 28 (32.9%) | 31 (37.8%) | |||
| 4–8 | 25 (30.9%) | 31 (36.5%) | 36 (43.9%) | |||
| Patients with an increase of | ||||||
| ≥1 WSL | 47 (58.0%) | 51 (60.0%) | 64 (78.0%) | .67 | .011 | .0059 |
| ≥2 WSL | 39 (48.1%) | 44 (51.8%) | 48 (58.5%) | .57 | .31 | .19 |
| ≥3 WSL | 29 (35.8%) | 34 (40.0%) | 37 (45.1%) | .66 | .39 | .25 |
Aesthetic zone includes teeth 3-3 in the maxillary and mandibular arches. P-value* is adjusted for baseline and treatment time.